Related Experiment Video
Updated: May 14, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Programmable Circular Single-Stranded DNA Acts as Recyclable Anti-miRNA Nucleotides to Inhibit Colorectal Cancer
Jinghao Wang1,2, Pengfei Zhang2,3,4, Guang Hu2,5
1Department of Chemistry, University of Science & Technology of China, Hefei, Anhui, China.
Abstract:
MicroRNA (miRNA) therapy represents an attractive approach for the treatment of colorectal cancer (CRC). However, the efficacy of therapy targeting a single oncomiRNA (oncomiR) is limited, as multiple oncomiRs often act simultaneously in promoting CRC development. In addition, current anti-miRNA nucleotide (AMiN) design faces challenges, including high synthetic error rate and difficulty in synthesizing long oligonucleotides. Circular single-stranded DNA (CssDNA), an ancient form of DNA that has gained increasing attention recently, is known for its easy synthesis, high stability, low error rate, and long size potential. Here, we develop a multi-oncomiR targeting platform with low immunogenicity, high stability and long-size potential using in vivo M13 phage-generated CssDNA. This CssDNA acts as a sponge, which attracts and degrades multiple abnormally overexpressed oncomiRs in CRC. The degradation of oncomiRs promotes the expression of tumor suppressor genes (TSGs), inhibiting CRC development. Further, the degradation of oncomiRs from the sponge releases the free CssDNA for second round of action, which results in the efficacy and recyclability of CssDNA. It's visible to spread this novel, sequence customizable, multi-oncomiR targeting platform using CssDNA as a stable, low-immunogenic and recyclable AMiN in antagonizing miRNA-mediated repression of TSG expression for other tumor suppression.
Insights
This study introduces circular single-stranded DNA (CssDNA) as a novel platform for colorectal cancer (CRC) therapy. CssDNA effectively targets multiple oncomiRs, restoring tumor suppressor gene expression and offering a stable, recyclable treatment option.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- MicroRNA (miRNA) therapy shows promise for colorectal cancer (CRC) treatment.
- Targeting single oncomiRs has limited efficacy due to simultaneous action of multiple oncomiRs in CRC.
- Current anti-miRNA nucleotide (AMiN) designs face challenges like high synthetic error rates and difficulty in synthesizing long oligonucleotides.
Purpose of the Study:
- To develop a novel, stable, and recyclable multi-oncomiR targeting platform for colorectal cancer (CRC) therapy.
- To utilize circular single-stranded DNA (CssDNA) as a superior alternative to conventional AMiNs.
- To demonstrate the efficacy of CssDNA in degrading multiple oncomiRs and restoring tumor suppressor gene (TSG) expression.
Main Methods:
- Development of a multi-oncomiR targeting platform using in vivo M13 phage-generated circular single-stranded DNA (CssDNA).
- CssDNA designed to act as a sponge, attracting and degrading multiple overexpressed oncomiRs in CRC.
- Assessment of CssDNA's stability, low immunogenicity, recyclability, and efficacy in promoting TSG expression.
Main Results:
- Engineered CssDNA demonstrated high stability, low immunogenicity, and potential for long oligonucleotide synthesis.
- CssDNA effectively sponged and degraded multiple oncogenic miRNAs (oncomiRs) in colorectal cancer models.
- Degradation of oncomiRs led to the restoration of tumor suppressor gene (TSG) expression, inhibiting CRC progression.
- Released CssDNA exhibited recyclability, enabling a second round of therapeutic action.
Conclusions:
- Circular single-stranded DNA (CssDNA) presents a promising, stable, and recyclable platform for multi-oncomiR targeting in colorectal cancer (CRC) therapy.
- This novel CssDNA-based approach offers advantages over traditional anti-miRNA nucleotide (AMiN) designs.
- The sequence-customizable CssDNA platform holds potential for antagonizing miRNA-mediated repression of tumor suppressor genes in various cancer treatments.
More Related Videos
Related Concept Videos
Experimental RNAi
MicroRNAs
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
piRNA - Piwi-interacting RNAs

